The NIH RMP Project
Induced pluripotent stem cell (iPSC) technology is transforming biological research. iPSCs behave like embryonic stem cells and have the potential to become any cell type of the human body and can be used as a tool to study human diseases, for drug discovery, and to develop cell therapies. The Regenerative Medicine Program (RMP) is developing resources to catalyze therapeutic use of iPSCs. The RMP has generated 14 research grade iPSC lines that are available to the scientific community through the NHCDR and RUCDR Infinite Biologics.